Farr Miller & Washington’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $33.1M | Buy |
263,716
+25,926
| +11% | +$3.36M | 2.15% | 25 |
|
|
2021
Q2 | $29.5M | Buy |
237,790
+541
| +0.2% | +$67.9K | 1.93% | 25 |
|
|
2021
Q1 | $28M | Buy |
237,249
+7,546
| +3% | +$884K | 1.97% | 24 |
|
|
2020
Q4 | $26.9M | Sell |
229,703
-600
| -0.3% | -$66.1K | 2.05% | 23 |
|
|
2020
Q3 | $23.9M | Sell |
230,303
-56,918
| -20% | -$5.72M | 2.07% | 21 |
|
|
2020
Q2 | $26.3M | Sell |
287,221
-4,835
| -2% | -$464K | 2.15% | 22 |
|
|
2020
Q1 | $26.3M | Sell |
292,056
-1,025
| -0.3% | -$109K | 2.48% | 19 |
|
|
2019
Q4 | $33.3M | Buy |
293,081
+918
| +0.3% | +$101K | 2.4% | 23 |
|
|
2019
Q3 | $31.7M | Buy |
292,163
+969
| +0.3% | +$101K | 2.53% | 20 |
|
|
2019
Q2 | $28.4M | Sell |
291,194
-5,072
| -2% | -$463K | 2.34% | 22 |
|
|
2019
Q1 | $27M | Buy |
296,266
+1,759
| +0.6% | +$157K | 2.3% | 24 |
|
|
2018
Q4 | $26.8M | Buy |
294,507
+2,081
| +0.7% | +$194K | 2.55% | 18 |
|
|
2018
Q3 | $28.8M | Sell |
292,426
-596
| -0.2% | -$55.1K | 2.43% | 20 |
|
|
2018
Q2 | $25.1M | Sell |
293,022
-4,383
| -1% | -$366K | 2.27% | 21 |
|
|
2018
Q1 | $23.9M | Sell |
297,405
-793
| -0.3% | -$65.4K | 2.22% | 22 |
|
|
2017
Q4 | $24.1M | Sell |
298,198
-66
| -0% | -$5.29K | 2.15% | 23 |
|
|
2017
Q3 | $23.2M | Sell |
298,264
-3,501
| -1% | -$291K | 2.21% | 23 |
|
|
2017
Q2 | $26.8M | Sell |
301,765
-2,146
| -0.7% | -$181K | 2.62% | 16 |
|
|
2017
Q1 | $24.5M | Buy |
303,911
+2,789
| +0.9% | +$218K | 2.54% | 17 |
|
|
2016
Q4 | $21.4M | Sell |
301,122
-14,502
| -5% | -$1.14M | 2.31% | 24 |
|
|
2016
Q3 | $27.3M | Buy |
315,624
+1,036
| +0.3% | +$90.3K | 2.97% | 10 |
|
|
2016
Q2 | $27.3M | Buy |
314,588
+1,799
| +0.6% | +$145K | 3.08% | 7 |
|
|
2016
Q1 | $23.5M | Sell |
312,789
-1,766
| -0.6% | -$133K | 2.71% | 13 |
|
|
2015
Q4 | $24.2M | Buy |
314,555
+1,216
| +0.4% | +$91.5K | 2.87% | 11 |
|
|
2015
Q3 | $21M | Sell |
313,339
-2,521
| -0.8% | -$186K | 2.69% | 14 |
|
|
2015
Q2 | $23.4M | Sell |
315,860
-2,328
| -0.7% | -$178K | 2.71% | 11 |
|
|
2015
Q1 | $24.8M | Sell |
318,188
-145,990
| -31% | -$11.1M | 2.85% | 8 |
|
|
2014
Q4 | $33.5M | Buy |
464,178
+17,733
| +4% | +$1.23M | 3.9% | 2 |
|
|
2014
Q3 | $27.7M | Buy |
446,445
+755
| +0.2% | +$48K | 3.6% | 4 |
|
|
2014
Q2 | $28.4M | Sell |
445,690
-1,542
| -0.3% | -$93.7K | 3.65% | 4 |
|
|
2014
Q1 | $27.5M | Buy |
447,232
+4,652
| +1% | +$271K | 3.77% | 3 |
|
|
2013
Q4 | $25.4M | Buy |
442,580
+9,518
| +2% | +$540K | 3.53% | 4 |
|
|
2013
Q3 | $23.1M | Sell |
433,062
-1,193
| -0.3% | -$64.2K | 3.68% | 3 |
|
|
2013
Q2 | $22.4M | Buy |
+434,255
| New | +$21.5M | 3.65% | 2 |
|
Other funds holding MDT
WA
Farr Miller & Washington's MDT Position: Q3 2021 in Review
Farr Miller & Washington increased its Medtronic (MDT) stake by 11% in Q3 2021, buying an estimated $3.36M and bringing the position to 263,716 shares worth $33.1M. The position accounts for 2.15% of the portfolio, ranked #25.
Farr Miller & Washington first reported a position in MDT in Q2 2013 and has held it in 34 quarters since. The position peaked at $33.5M in Q4 2014. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.
- Farr Miller & Washington held 263,716 shares of Medtronic worth $33.1M as of Q3 2021.
- Farr Miller & Washington bought 25,926 Medtronic shares in Q3 2021, an estimated $3.36M.
- Medtronic made up 2.15% of Farr Miller & Washington's portfolio in Q3 2021, its #25 holding.
- Farr Miller & Washington first reported a position in Medtronic in Q2 2013 and has held it in 34 quarters since.
- Farr Miller & Washington's Medtronic position peaked at $33.5M in Q4 2014.
- 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.
Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.